# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001144204-18-010571
Filing Date
2018-02-23
Accepted
2018-02-23 16:31:57
Documents
5
Period of Report
2018-02-23

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PRE 14A | tv486790_pre14a.htm | PRE 14A | 524083
2 | GRAPHIC | tv486790_img1.jpg | GRAPHIC | 9854
3 | GRAPHIC | tv486790_img2.jpg | GRAPHIC | 4141
4 | GRAPHIC | tv486790_proxycard1.jpg | GRAPHIC | 340373
5 | GRAPHIC | tv486790_proxycard2.jpg | GRAPHIC | 102858
| Complete submission text file | 0001144204-18-010571.txt |  | 1145332

Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-33357 | Film No.: 18636987
SIC: 2836 Biological Products, (No Diagnostic Substances)